Zobrazeno 1 - 10
of 584
pro vyhledávání: '"Walter M. Stadler"'
Autor:
Daniel Huang, Connor Lynch, Lucas M. Serra, Randy F. Sweis, Paul J. Chang, Walter M. Stadler, Russell Z. Szmulewitz, Peter H. O’Donnell, Abhinav Sidana, Scott E. Eggener, Arieh L. Shalhav, Stanley L. Liauw, Sean P. Pitroda
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100879- (2024)
Background and purpose: Stereotactic ablative body radiotherapy (SABR) is an effective treatment for localized renal cell carcinoma (RCC). However, the role of primary site SABR for locally recurrent or metastatic RCC is unclear. Here, we report outc
Externí odkaz:
https://doaj.org/article/1a67d80417974116897b0aff6bb0ac82
Autor:
Walter M. Stadler, MD
Utilizing the teaching value of real-world case discussions, Cancer Biology Review presents the principles of cancer biology in a clear and memorable manner, allowing the clinician to relate the cases shown in the book to those seen in practice. Focu
Autor:
Jacobi Hines, Ellen Daily, Anh Khoa Pham, Christopher R. Shea, Urooba Nadeem, Aliya N. Husain, Walter M. Stadler, Pankti Reid
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Abstract Background Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive malignancies continues to reveal a range of immune-related adverse events (irAEs),
Externí odkaz:
https://doaj.org/article/f8fa5a9ee6324348a03a4c3dc1155404
Autor:
Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford, Lisa F. Newcomb, Suzanne Kolb, Antonio Finelli, Neil E. Fleshner, Maria Komisarenko, James A. Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J. Logothetis, Justin R. Gregg, Cherie A. Perez, Sergio Garza, Jeri Kim, Leonard S. Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H. Klotz, Andrew Loblaw, Alexandre Mamedov, S. Larry Goldenberg, Celestia S. Higano, Maria Spillane, Eugenia Wu, H. Ballentine Carter, Christian P. Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R. Carroll, June M. Chan, Matthew R. Cooperberg, Janet E. Cowan, Todd M. Morgan, Javed Siddiqui, Rabia Martin, Eric A. Klein, Karen Brittain, Paige Gotwald, Daniel A. Barocas, Jeremiah R. Dallmer, Jennifer B. Gordetsky, Pam Steele, Shilajit D. Kundu, Jazmine Stockdale, Monique J. Roobol, Lionne D.F. Venderbos, Martin G. Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P. Evans, Marc A. Dall’Era, Anjali Vij, Anthony J. Costello, Ken Chow, Niall M. Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S. Scherr, Thomas Flynn, R. Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B. Nelson, Dawn McBride, Michael S. Cookson, Kelly L. Stratton, Stephen Farriester, Erin Hemken, Walter M. Stadler, Tuula Pera, Deimante Banionyte, Fernando J. Bianco, Jr., Isabel H. Lopez, Stacy Loeb, Samir S. Taneja, Nataliya Byrne, Christopher L. Amling, Ann Martinez, Luc Boileau, Franklin D. Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T. Helfand, Jianfeng Xu, Denise M. Scholtens, William J. Catalona, John S. Witte
Publikováno v:
HGG Advances, Vol 3, Iss 1, Pp 100070- (2022)
Summary: Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active
Externí odkaz:
https://doaj.org/article/dd671a3166f5492e9f3db2429cd59265
Autor:
Craig Labbate, Ken Hatogai, Ryan Werntz, Walter M. Stadler, Gary D. Steinberg, Scott Eggener, Randy F. Sweis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-6 (2019)
Abstract Background Clinically localized renal cell carcinoma is treated primarily with surgery followed by observation or adjuvant sunitinib in selected high-risk patients. The checkpoint inhibitor immunotherapeutic agents nivolumab and ipilimumab h
Externí odkaz:
https://doaj.org/article/d5be1d58c2bd4f0dab13fa116eaaa105
Autor:
Hongtao Liu, Elad Sharon, Theodore G. Karrison, Yuanyuan Zha, Noreen Fulton, Howard Streicher, Kendra Sweet, George Yaghmour, Jane Jijun Liu, Brian A. Jonas, Aaron D. Schimmer, Steven Grant, Amer M. Zeidan, Gerhard C. Hildebrandt, Christopher S. Hourigan, Christopher H. Lowrey, Ryan J. Mattison, Neil Palmisiano, Amandeep Salhotra, Dimitrios Tzachanis, Maria R. Baer, Tara L. Lin, Prapti Patel, Helen Chen, Walter M. Stadler, Olatoyosi Odenike, Richard A. Larson, Thomas F. Gajewski, Wendy Stock
Publikováno v:
Blood. 140:1716-1719
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04fb86e72e5c0992e5a0b3818bc47b3a
https://doi.org/10.1182/blood-2022-157326
https://doi.org/10.1182/blood-2022-157326
Autor:
Nizar M. Tannir, Neeraj Agarwal, Camillo Porta, Nicola J. Lawrence, Robert Motzer, Bradley McGregor, Richard J. Lee, Rohit K. Jain, Nancy Davis, Leonard J. Appleman, Oscar Goodman, Walter M. Stadler, Sunil Gandhi, Daniel M. Geynisman, Roberto Iacovelli, Begoña Mellado, Juan Manuel Sepúlveda Sánchez, Robert Figlin, Thomas Powles, Lalith Akella, Keith Orford, Bernard Escudier
Publikováno v:
JAMA oncology. 8(10)
ImportanceDysregulated metabolism is a hallmark of renal cell carcinoma (RCC). Glutaminase is a key enzyme that fuels tumor growth by converting glutamine to glutamate. Telaglenastat is an investigational, first-in-class, selective, oral glutaminase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d814d8a9fe7e9265f06d2c12c2ccd89d
https://pubmed.ncbi.nlm.nih.gov/36048459
https://pubmed.ncbi.nlm.nih.gov/36048459
Autor:
Richard T. Lee, Joshua A. Hemmerich, Nancy Kwon, Kathryn Bylow, Walter M. Stadler, Supriya G. Mohile, William Dale
Publikováno v:
Family Medicine and Community Health, Vol 5, Iss 2, Pp 139-148 (2017)
Objective: We aimed to explore associations between anxiety and specific health behaviors such as complementary and alternative medicine (CAM), diet, and exercise among prostate cancer patients. Methods: PCa patients enrolled in a prospective cohort
Externí odkaz:
https://doaj.org/article/f8c4f128b98e4299a38261be90975107
Autor:
Ari J. Rosenberg, Chih-Yi Liao, Theodore Karrison, Jonas A. de Souza, Francis P. Worden, Bernadette Libao, Monika K. Krzyzanowska, D. Neil Hayes, Eric Winquist, Vassiliki Saloura, Kevin Prescott, Victoria M. Villaflor, Tanguy Y. Seiwert, Rebecca B. Schechter, Walter M. Stadler, Ezra E.W. Cohen, Everett E. Vokes
Publikováno v:
Annals of Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cda650fd4cb3a0760318a6f3cc8966b
https://doi.org/10.1016/j.annonc.2023.05.002
https://doi.org/10.1016/j.annonc.2023.05.002
Publikováno v:
JAMA Oncology.
This quality improvement study examines the difficulties of patient accrual among patients with cancer and SETD2 variants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d203da52843b7bfaf66403b405c053
https://doi.org/10.1001/jamaoncol.2023.0248
https://doi.org/10.1001/jamaoncol.2023.0248